Related Experiment Video
Updated: Dec 13, 2025

04:04
Lateral Molar Approach-Driven Transoral Endoscopic Procedure for Benign Infratemporal Fossa Tumor Resection
Published on: August 15, 2025
245
Calcifying Fibrous Tumor Complicated by Empyema
Nikita Jain1, Anchit Bharat2, Nadiia Marenych1
1Internal Medicine, Chicago Medical School, Rosalind Franklin University of Medicine and Science, McHenry, USA.
Cureus
|July 28, 2020
Summary
Calcifying fibrous tumor (CFT) is a rare, benign tumor. Early diagnosis of this pleural-based mass is crucial to avoid aggressive surgery and complications.
Area of Science:
- Oncology
- Pathology
Background:
- Calcifying fibrous tumor (CFT) is a rare, benign neoplastic proliferation.
- Characterized by fibroblasts, inflammatory cells, and calcification, CFT typically presents as a non-invasive lesion in deep tissue structures.
Observation:
- A case study details a 43-year-old Hispanic male with a large, symptomatic pleural-based mass.
- The mass was diagnosed as CFT and subsequently complicated by empyema.
Findings:
- The patient's large CFT necessitated extensive chest wall reconstruction.
- This aggressive surgical approach led to postoperative complications.
Implications:
- Increased awareness of CFT is vital for early recognition and diagnosis.
- Prompt diagnosis can prevent the need for extensive surgery, reducing complications and improving patient outcomes.
- Highlighting the benign nature of CFT despite its alarming imaging appearance is essential for appropriate clinical management.
Related Concept Videos
The Tumor Microenvironment
7.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.5K
Pulmonary Tuberculosis II
1.2K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.2K
Pneumonia III: Complications and Assessment
678
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
678
Endoscopic Studies II: Thoracocentesis
1.0K
Thoracentesis(Thoracocentesis), commonly known as pleural tap, is a medical procedure where a 22 gauge needle is inserted into the pleural space, the area between the lung and chest wall. This procedure is commonly performed to diagnose or treat various respiratory disorders.
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
1.0K
Cystic Fibrosis: Management
338
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
338
Flail Chest-II
420
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
420
